Next week’s primary market slows for large offerings but stays active for SMEs. Three SME IPOs aim to raise about Rs 100 crore, while two recently closed mainboard issues—Excelsoft Technologies and Sudeep Pharma—are set to list. No new mainboard IPOs open for subscription, with action concentrated in smaller deals.
After a hectic run of big-ticket issues, the upcoming week features no new mainboard IPO subscriptions, but three SME IPOs are scheduled to open, collectively targeting close to Rs 100 crore. Market watchers expect activity to center on SSMD Agrotech India and K K Silk Mills, with price bands and timelines already disclosed, while one more SME offer rounds out the slate.
Two mainboard listings will headline the week. Excelsoft Technologies is tentatively slated to debut on November 26, and Sudeep Pharma on November 28, both on BSE and NSE. These listings follow the closure of their issues and finalisation of allotments, offering investors fresh post-listing cues in a quieter subscription environment.
The SME calendar opens with SSMD Agrotech India IPO from November 25 to 27, a fresh issue of 0.28 crore shares amounting to Rs 34.09 crore, priced in the Rs 114–121 band. K K Silk Mills is expected to open on November 25, with a price band in the mid-30s per share, continuing the pattern of smaller, sector-focused raises with streamlined registrars and managers.
Key highlights
-
No new mainboard IPOs are opening for subscription next week; the focus shifts to SMEs.
-
Three SME IPOs are set to open, collectively targeting about Rs 100 crore.
-
Excelsoft Technologies and Sudeep Pharma are scheduled to list on November 26 and November 28, respectively.
-
SSMD Agrotech India IPO runs November 25–27; fresh issue Rs 34.09 crore; price band Rs 114–121.
-
K K Silk Mills IPO opens next week with a sub-Rs 40 price band, per market schedules.
-
Primary market pace moderates after recent heavy activity in mainboard names.
Outlook
With fewer large subscriptions, attention will concentrate on listing performance and SME fundraising quality. Price discovery in Excelsoft Technologies and Sudeep Pharma could guide sentiment, while SME execution and investor interest will indicate depth of demand in the smaller-cap segment.
Sources: Mint; Times Now; Financial Express; The Economic Times.